Interest Expense in USD of Orchard Therapeutics plc from Q2 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Orchard Therapeutics plc quarterly/annual Interest Expense history and change rate from Q2 2019 to Q3 2023.
  • Orchard Therapeutics plc Interest Expense for the quarter ending 30 Sep 2023 was $932K, a 16.6% increase year-over-year.
  • Orchard Therapeutics plc Interest Expense for the twelve months ending 30 Sep 2023 was $3.8M, a 34.2% increase year-over-year.
  • Orchard Therapeutics plc annual Interest Expense for 2022 was $3.08M, a 23.3% increase from 2021.
  • Orchard Therapeutics plc annual Interest Expense for 2021 was $2.5M, a 7.26% increase from 2020.
  • Orchard Therapeutics plc annual Interest Expense for 2020 was $2.33M, a 51.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Orchard Therapeutics plc Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $3.8M $932K +$133K +16.6% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $3.66M $975K +$303K +45.1% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $3.36M $957K +$282K +41.8% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $3.08M $933K +$250K +36.6% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2023
Q3 2022 $2.83M $799K +$116K +17% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $2.71M $672K +$79K +13.3% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $2.63M $675K +$137K +25.5% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $2.5M $683K +$108K +18.8% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 $2.39M $683K +$111K +19.4% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $2.28M $593K +$25K +4.4% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $2.25M $538K -$75K -12.2% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $2.33M $575K 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $572K -$88K -13.3% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $568K +$323K +132% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $613K 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q3 2019 $660K 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020
Q2 2019 $245K 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020

Orchard Therapeutics plc Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.08M +$582K +23.3% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2023
2021 $2.5M +$169K +7.26% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 $2.33M +$790K +51.4% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $1.54M 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.